Cheng-Han Tsai

Cheng-Han Tsai

Auto-generated profile, based on publicly available information

Cheng-Han Tsai

Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
CTCheng-Han Tsai
Cheng-Han Tsai
LLLiang-ting LIN
Liang-ting LIN
CWChung-Yih Wang
Chung-Yih Wang
YCYu-Wen Chiu
Yu-Wen Chiu
YCYen-Ting Chou
Yen-Ting Chou
Yi-Jang LeeYi-Jang Lee
Yi-Jang Lee

12 March 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
WKWei-Ying Kuo
Wei-Ying Kuo
CWChun-Yi Wu
Chun-Yi Wu
LHLuen Hwu
Luen Hwu
JLJhih-Shian Lee
Jhih-Shian Lee
CTCheng-Han Tsai
Cheng-Han Tsai
RLRen-Shyan Liu
Ren-Shyan Liu
Cancer stem cells (CSCs) are usually tolerant to chemotherapy and radiotherapy and associated with tumor relapse. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor (HDACI), is currently being used in clinical trials of lung cancer. However, SAHA facilitates the formation of induced pluripotent stem cells from somatic cells. We hypothesized that SAHA would mediate the CSCs properties and subsequently confer a more malignant phenotype in lung cancer. Transfected H1299 lung cancer cells, which stably expresses a triple fused reporter gene (DsRedm-Fluc-tTKsr39) under the control of CMV promoter was used to establish a xenograft mouse model. After the treatment of SAHA, H1299 cell line and tumor xenografts were sorted by fluorescence-activated cell sorting (FACS) based on aldehyde dehydrogenase (ALDH) activity. We found that SAHA could suppress the growth of xenografted H1299 tumors with decreased proportion of ALDHbr lung cancer cells indicating that SAHA may target CSCs. However, SAHA significantly enhanced the tumor initiating capacity and the expression of malignant genes such as KCNMA1, MORF4L2 and ASPM in the remaining living ALDHbr cells. These findings suggested that SAHA treatment created a more drug-resistant state in residual ALDHbr cells. The in vivo imaging technique may facilitate searching and characterization of CSCs.